Alpine Immune Sciences Stock Price To Book
| ALPNDelisted Stock | USD 12.37 0.23 1.83% |
Alpine Immune Sciences fundamentals help investors to digest information that contributes to Alpine Immune's financial success or failures. It also enables traders to predict the movement of Alpine Stock. The fundamental analysis module provides a way to measure Alpine Immune's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Alpine Immune stock.
Alpine |
Alpine Immune Sciences Company Price To Book Analysis
Alpine Immune's Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Current Alpine Immune Price To Book | 12.87 X |
Most of Alpine Immune's fundamental indicators, such as Price To Book, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Alpine Immune Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
CompetitionBased on the latest financial disclosure, Alpine Immune Sciences has a Price To Book of 12.8686 times. This is 49.89% lower than that of the Biotechnology sector and 113.06% higher than that of the Health Care industry. The price to book for all United States stocks is 35.32% lower than that of the firm.
Alpine Price To Book Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Alpine Immune's direct or indirect competition against its Price To Book to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Alpine Immune could also be used in its relative valuation, which is a method of valuing Alpine Immune by comparing valuation metrics of similar companies.Alpine Immune is currently under evaluation in price to book category among its peers.
Alpine Fundamentals
| Return On Equity | -0.15 | |||
| Return On Asset | -0.1 | |||
| Profit Margin | (0.65) % | |||
| Operating Margin | (3.23) % | |||
| Current Valuation | 4.16 B | |||
| Shares Outstanding | 68.6 M | |||
| Shares Owned By Insiders | 4.60 % | |||
| Shares Owned By Institutions | 99.46 % | |||
| Number Of Shares Shorted | 3.89 M | |||
| Price To Earning | (32.69) X | |||
| Price To Book | 12.87 X | |||
| Price To Sales | 71.68 X | |||
| Revenue | 58.88 M | |||
| Gross Profit | (40.18 M) | |||
| EBITDA | (43.67 M) | |||
| Net Income | (32.18 M) | |||
| Cash And Equivalents | 167.86 M | |||
| Cash Per Share | 5.52 X | |||
| Total Debt | 9.91 M | |||
| Debt To Equity | 0.17 % | |||
| Current Ratio | 2.75 X | |||
| Book Value Per Share | 5.08 X | |||
| Cash Flow From Operations | (79.01 M) | |||
| Short Ratio | 0.96 X | |||
| Earnings Per Share | (0.64) X | |||
| Target Price | 62.0 | |||
| Number Of Employees | 142 | |||
| Beta | 0.97 | |||
| Market Capitalization | 4.46 B | |||
| Total Asset | 381.81 M | |||
| Retained Earnings | (256.14 M) | |||
| Working Capital | 288.05 M | |||
| Current Asset | 25.53 M | |||
| Current Liabilities | 3.39 M | |||
| Net Asset | 381.81 M |
About Alpine Immune Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Alpine Immune Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Alpine Immune using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Alpine Immune Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Consideration for investing in Alpine Stock
If you are still planning to invest in Alpine Immune Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Alpine Immune's history and understand the potential risks before investing.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |